Skip to main content

Table 5 Concomitant medication use* of HIV patients with or without chronic non HBV/HCV hepatitis**

From: Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection

Concomitant medications

Case

Control

p value

 

(n = 124)

(n = 124)

 

o Isoniazid

17(13.7)

22(17.7)

0.36

o Pyrazinamide

7(5.6)

6(4.8)

0.78

o Gemfibrosil

7(5.6)

7(5.6)

1.0

o Fenofibrate

11(8.8)

8(6.5)

0.47

o Simvastatin

7(5.6)

5(4.0)

0.53

o Cotrimoxazole

50(40.3)

50(40.3)

1.0

o Dapsone

4(3.2)

3(2.4)

0.71

o Fluconazole

19(15.3)

14(11.3)

0.30

o Analgesic

14(11.3)

17(13.7)

0.33

  1. Footnote:
  2. * Ever exposed to any concomitant medications.
  3. ** Chronic hepatitis was defined as those with elevated ALT ≥ 40 IU/L at 2 consecutive visits 6 months apart.